Endometrial Cancer Guidelines Working Party members

From Cancer Guidelines Wiki

Endometrial Cancer Guidelines Working Party members

Name Affiliation
Dr Alison Brand (Chair) Gynaecological Oncologist – Westmead Hospital, Sydney NSW
Professor Ian Hammond (Deputy Chair) Gynaecological Oncologist, Cancer Australia Advisory Group/ King Edward Memorial Hospital, Perth WA
Dr Robyn Cheuk Radiation Oncologist, Cancer Australia Advisory Group/ Royal Brisbane and Womens Hospital, Brisbane QLD
Kathryn Crisell Gynaecological cancer consumer, Adelaide SA
Associate Professor Margaret Davy Gynaecological Oncologist, Cancer Australia Advisory Group/ Royal Adelaide Hospital, Adelaide SA
Dr Andrew Dean Medical Oncologist, St John of God Hospital, Perth WA
Dr Louise Farrell Gynaecologist, King Edward Memorial Hospital, Perth WA
Jane Francis Manager - Gynaecological Cancers, Cancer Australia
Clinical Associate Professor Russell Hogg Gynaecological Oncologist, Westmead Hospital, Sydney NSW
Lesley McQuire Gynaecological cancer consumer, Sydney NSW
Dr Selvan Pather Gynaecological Oncologist, Royal Prince Alfred Hospital, Sydney NSW
Dr Frances Quirk Sexologist, Townsville QLD
Dr Felicity Rea General Practitioner, Toowoomba QLD
Dr Colin Stewart Histopathologist, WA
Ella Curnow Project Officer - Cancer Australia
Professor Ian Olver AM (Convenor) CEO - Cancer Council Australia
Christine Vuletich Manager - Clinical Guidelines Network, Cancer Council Australia
Alice Winter-Irving Project Officer - Clinical Guidelines Network, Cancer Council Australia
Jutta von Dincklage Project Manager - Wiki Development, Cancer Council Australia

Back to top

Topic authors and contributors

Clinical question Question authors and contributors
Multidisciplinary care
Is there benefit for multidisciplinary care of women with low and high-risk apparent early stage endometrial cancer? Ai Ling Tan - Gynaecological Oncologist Auckland, New Zealand

Jane Francis - Manager, Gynaecological Cancers, Cancer Australia

Pre-operative
What is the role of preoperative imaging for low and high risk apparent early stage endometrial cancer? Ian Hammond - Gynaecological Oncologist, WA

Stuart Salfinger - Gynaecological Oncologist WA
Elizabeth Dillon – Diagnostic Radiologist, WA

Is there a benefit to a histopathological review of currettings or biopsy prior to treatment in low and high risk apparent early stage endometrial cancer? Russell Hogg - Gynaecological Oncologist, NSW
Surgery
What is the evidence based surgical approach for hysterectomy in low and high risk apparent early stage endometrial cancer? Andreas Obermair - Gynaecological Oncologist QLD

Kym Reid - Gynaecological Oncology Fellow, QLD

What is the evidence based surgical approach for bilateral salpingo–oophorectomy in premenopausal women with low and high risk apparent early stage endometrial cancer? Margaret Davy - Gynaecological Oncologist, SA

Alison Brand - Gynaecological Oncologist, NSW

What is the evidence based surgical approach for lymphadenectomy in low and high risk apparent early stage endometrial cancer? Selvan Pather - Gynaecological Oncologist NSW

Marcelo Nascimento - Gynaecological Oncologist, QLD

What is the role of intra-operative assessment of the uterus in low and high risk apparent early stage endometrial cancer? Colin Stewart - Histopathologist, WA

Alison Brand - Gynaecological Oncologist, NSW

Adjuvant Therapy
After hysterectomy, what is the role of radiotherapy (external beam, brachytherapy) in the management of early stage high risk endometrial cancer? Robyn Cheuk – Radiation Oncologist, QLD

Olivia Bigault – Radiation Oncology Fellow, QLD

After hysterectomy, what is the role of chemotherapy (concurrent/concomitant, sequential, sandwich, chemoradiation) in the management of early stage high risk endometrial cancer? Andrew Dean – Medical Oncologist, WA

Linda Mileshkin- Medical Oncologist, VIC

Back to top